Superior lateral genicular nerve (SLGN)

The superior lateral genicular nerve (SLGN) is a sensory peripheral nerve that provides crucial innervation to the superolateral aspect of the knee joint capsule [1]. It usually originates from the common fibular (peroneal) nerve or the sciatic nerve and follows a course along the lateral femoral shaft, passing near the superior border of the lateral femoral epicondyle [2, 3]. While the SLGN is an anatomical structure rather than a single molecular target, it is a significant clinical target for interventional pain management, specifically in genicular nerve blocks and radiofrequency ablation (RFA) [1]. These procedures are primarily indicated for patients with chronic knee pain resulting from osteoarthritis or for those who continue to experience pain following total knee arthroplasty [1, 4]. Pharmacological targeting of the nerve involves the use of local anesthetics, such as lidocaine or bupivacaine, which bind to and inhibit voltage-gated sodium channels on the neuronal membrane, thereby preventing the transmission of nociceptive signals [5]. In chronic cases, neuroablative techniques use thermal energy to create lesions in the nerve, providing long-term relief by disrupting the physical integrity of the pain transmission pathway [1, 3]. Citations: [1] StatPearls, Genicular Nerve Block; [2] Journal of Clinical Medicine, Anatomy of Genicular Nerves; [3] Clinical Anatomy, Innervation of the knee joint; [4] NIH, Interventional management of knee pain; [5] PubChem, Lidocaine Mechanism.

Other names

SLGNSuperior lateral genicular branch of the common fibular nerveSuperior lateral genicular branch of the common peroneal nerve

Inhibition of voltage-gated sodium channels via local anesthetics to block action potential propagation; Thermal neurotomy via radiofrequency ablation to physically disrupt nerve conductivity.